These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26067573)

  • 21. Clinical management of women presenting with field effect of HPV and intraepithelial disease.
    Adams TS; Mbatani NH
    Best Pract Res Clin Obstet Gynaecol; 2018 Feb; 47():86-94. PubMed ID: 29030149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for human papillomavirus testing in clinical practice?
    Kaufman RH
    Obstet Gynecol; 2001 Nov; 98(5 Pt 1):724-5. PubMed ID: 11704159
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical implications of transitioning from cytology to human papillomavirus-based cervical cancer screening.
    Hammer A; Gravitt P
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):371-372. PubMed ID: 33739440
    [No Abstract]   [Full Text] [Related]  

  • 24. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology.
    Sharpless KE; O'Sullivan DM; Schnatz PF
    J Low Genit Tract Dis; 2009 Apr; 13(2):72-8. PubMed ID: 19387126
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1.
    Boardman LA; Kennedy CM
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):599-614; ix. PubMed ID: 19061819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
    Wright TC
    Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S239-46. PubMed ID: 17161163
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening based on papillomavirus detection: too many false alarms.
    Prescrire Int; 2010 Aug; 19(108):178-9. PubMed ID: 20939456
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laboratory management of cervical intraepithelial neoplasia: proposing a new paradigm.
    Herfs M; Crum CP
    Adv Anat Pathol; 2013 Mar; 20(2):86-94. PubMed ID: 23399794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical screening in adolescents--at least do no harm.
    Szarewski A; Sasieni P
    Lancet; 2004 Nov 6-12; 364(9446):1642-4. PubMed ID: 15530605
    [No Abstract]   [Full Text] [Related]  

  • 30. [Methods of cervical cancer screening and facing new problems in China].
    Zhang WH
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):881-4. PubMed ID: 19173985
    [No Abstract]   [Full Text] [Related]  

  • 31. [The HPV test in primary cervical cancer screening].
    Bergeron C
    Ann Pathol; 2008 Nov; 28 Spec No 1(1):S90-1. PubMed ID: 18984315
    [No Abstract]   [Full Text] [Related]  

  • 32. Cervical screening in genitourinary medicine clinics--what are we trying to achieve?
    Bradbeer C; Navaratne L
    Sex Transm Infect; 1999 Oct; 75(5):286-7. PubMed ID: 10616349
    [No Abstract]   [Full Text] [Related]  

  • 33. Integrated human papillomavirus analysis as an adjunct for triage of atypical cervical cytology.
    Cheung AN; Wong OG; Chan KK; Yang MS; Tsang CH; Ji SL; Lo CK; Szeto E; Wong E; Ngan HY
    Hong Kong Med J; 2014 Dec; 20 Suppl 6():44-7. PubMed ID: 25482973
    [No Abstract]   [Full Text] [Related]  

  • 34. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.
    Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Strand AS; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
    Br J Cancer; 2018 Mar; 118(6):896-904. PubMed ID: 29438367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expanded use of human papillomavirus testing in gynecologic practice.
    Day S; Garces J
    Am J Clin Pathol; 2007 Nov; 128(5):886-8; author reply 888-90. PubMed ID: 18018332
    [No Abstract]   [Full Text] [Related]  

  • 36. 2012 cervical cancer screening guidelines and the future role of HPV testing.
    Priebe AM
    Clin Obstet Gynecol; 2013 Mar; 56(1):44-50. PubMed ID: 23337843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus DNA status after loop excision for cervical intraepithelial neoplasia grade III - A prospective study.
    Nagai N; Mukai K; Oshita T; Shiroyama Y; Ohama K
    Int J Mol Med; 2004 Apr; 13(4):589-93. PubMed ID: 15010861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended duration of the detectable stage by adding HPV test in cervical cancer screening.
    van den Akker-van Marie ME; van Ballegooijen M; Rozendaal L; Meijer CJ; Habbema JD
    Br J Cancer; 2003 Nov; 89(10):1830-3. PubMed ID: 14612887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening for cervical cancer.
    CA Cancer J Clin; 2020 Sep; 70(5):347-348. PubMed ID: 33460047
    [No Abstract]   [Full Text] [Related]  

  • 40. [HPV-Hr detection by home self sampling in women not compliant with pap test for cervical cancer screening. Results of a pilot programme in Bouches-du-Rhône].
    Piana L; Leandri FX; Le Retraite L; Heid P; Tamalet C; Sancho-Garnier H
    Bull Cancer; 2011 Jul; 98(7):723-31. PubMed ID: 21700548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.